接受根治性手术的胰腺导管腺癌患者术前CT生存预测因素
回顾性分析2006年12月至2017年7月接受根治性手术的168例胰腺导管腺癌患者,采用APA/SAR结构化报告模板评估术前CT特征与总生存的关联。全队列中任何动脉接触、肝总动脉接触和门静脉变形与总生存降低相关;直接手术组肿瘤较大与生存降低相关,新辅助治疗组仅静脉侧支与生存降低相关。应用该模板可能识别生存预测因素,有助于术前分层。
要点
- 全队列中门静脉变形与总生存降低相关(HR 3.22,95%CI 1.63-6.37,p=0.003)。
- 全队列中肝总动脉接触与总生存降低相关(HR 2.33,95%CI 1.35-4.04,p=0.009)。
- 新辅助治疗组中静脉侧支是唯一与总生存降低相关的特征(HR 2.28,95%CI 1.04-4.99,p=0.042)。
关键影像表现/征象
- 全队列中任何类型肿瘤动脉接触与总生存降低相关(HR 1.89,95%CI 1.13-3.14,p=0.020)。
- 全队列中肿瘤接触肝总动脉与总生存降低相关(HR 2.33,95%CI 1.35-4.04,p=0.009)。
- 全队列中门静脉变形与总生存降低相关(HR 3.22,95%CI 1.63-6.37,p=0.003)。
- 直接手术组中较大肿瘤与总生存降低相关(HR 2.30,95%CI 1.19-4.42,p=0.013)。
- 新辅助治疗组中静脉侧支是唯一与总生存降低相关的特征(HR 2.28,95%CI 1.04-4.99,p=0.042)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the associations between computed tomography (CT) imaging features extracted from the structured American Pancreatic Association (APA)/Society of Abdominal Radiology (SAR) template and overall survival in patients with resected pancreatic ductal adenocarcinoma (PDAC).
METHODS: This retrospective analysis included consecutive patients with PDAC who consented to genomic tumor testing and underwent preoperative imaging and curative intent surgical resection from December 2006 to July 2017. Two radiologists assessed preoperative CT imaging using the APA/SAR PDAC-reporting template. Univariable associations between overall survival and imaging variables were evaluated using Cox proportional hazards regression.
RESULTS: The study included 168 patients (66 years ± 11; 91 women). 126/168 patients (75%) received upfront surgical resection whereas 42/168 (25%) received neoadjuvant therapy prior to surgical resection. In the entire cohort, features associated with decreased overall survival were tumor arterial contact of any kind (hazard ratio (HR) 1.89, 95% CI 1.13-3.14, p = 0.020), tumor contact with the common hepatic artery (HR 2.33, 95% CI 1.35-4.04, p = 0.009), and portal vein deformity (HR 3.22, 95% CI 1.63-6.37, p = 0.003). In the upfront surgical group, larger tumor size was associated with decreased overall survival (HR 2.30, 95% CI 1.19-4.42, p = 0.013). In the neoadjuvant therapy group, the presence of venous collaterals was the only feature associated with decreased overall survival (HR 2.28, 95% CI 1.04-4.99, p = 0.042).
CONCLUSION: The application of the APA/SAR pancreatic adenocarcinoma reporting template may identify predictors of survival that can aid in preoperative stratification of patients.
引用
- Dickinson SM, McIntyre CA, Schilsky JB, et al. Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery. Abdom Radiol (NY). 2020. PMID: 32986175. doi:10.1007/s00261-020-02726-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。